Dezsi L - Search Results

1

Correlation of GAA Genotype and Acid-α-Glucosidase Enzyme Activity in Hungarian Patients with Pompe Disease.

Gal A, Grosz Z, Borsos B, Szatmari I, Sebők A, Jávor L, Harmath V, Szakszon K, Dezsi L, Balku E, Jobbagy Z, Herczegfalvi A, Almássy Z, Kerényi L, Molnar MJ. Gal A, et al. Among authors: dezsi l. Life (Basel). 2021 May 31;11(6):507. doi: 10.3390/life11060507. Life (Basel). 2021. PMID: 34072668 Free PMC article.

2

[The long-term follow-up of enzyme replacement treatment in late onset Pompe disease].

Molnár MJ, Borsos B, Várdi KV, Grosz Z, Sebők Á, Dézsi L, Almássy Z, Kerényi L, Jobbágy Z, Jávor L, Bidló J. Molnár MJ, et al. Among authors: dezsi l. Ideggyogy Sz. 2020 May 30;73(05-06):151-159. doi: 10.18071/isz.73.0151. Ideggyogy Sz. 2020. PMID: 32579304 Free article. Review. Hungarian.

3

NKX2-1 New Mutation Associated With Myoclonus, Dystonia, and Pituitary Involvement.

Balicza P, Grosz Z, Molnár V, Illés A, Csabán D, Gézsi A, Dézsi L, Zádori D, Vécsei L, Molnár MJ. Balicza P, et al. Among authors: dezsi l. Front Genet. 2018 Aug 22;9:335. doi: 10.3389/fgene.2018.00335. eCollection 2018. Front Genet. 2018. PMID: 30186310 Free PMC article.

4

Variant Transthyretin Amyloidosis (ATTRv) in Hungary: First Data on Epidemiology and Clinical Features.

Pozsonyi Z, Peskó G, Takács H, Csuka D, Nagy V, Szilágyi Á, Hategan L, Muk B, Csányi B, Nyolczas N, Dézsi L, Molnár JM, Csillik A, Révész K, Iványi B, Szabó F, Birtalan K, Masszi T, Arányi Z, Sepp R. Pozsonyi Z, et al. Among authors: dezsi l. Genes (Basel). 2021 Jul 28;12(8):1152. doi: 10.3390/genes12081152. Genes (Basel). 2021. PMID: 34440326 Free PMC article.

5

Clinical implications of irregular ADMET properties with levodopa and other antiparkinson's drugs.

Dézsi L, Vécsei L. Dézsi L, et al. Expert Opin Drug Metab Toxicol. 2014 Mar;10(3):409-24. doi: 10.1517/17425255.2014.878702. Epub 2014 Jan 17. Expert Opin Drug Metab Toxicol. 2014. PMID: 24437461 Review.

6

Monoamine Oxidase B Inhibitors in Parkinson's Disease.

Dezsi L, Vecsei L. Dezsi L, et al. CNS Neurol Disord Drug Targets. 2017;16(4):425-439. doi: 10.2174/1871527316666170124165222. CNS Neurol Disord Drug Targets. 2017. PMID: 28124620 Review.

7

Established therapies and novel targets in the treatment of Parkinson's disease.

Dézsi L, Vécsei L. Dézsi L, et al. Expert Rev Clin Pharmacol. 2009 Nov;2(6):631-44. doi: 10.1586/ecp.09.47. Expert Rev Clin Pharmacol. 2009. PMID: 22112257

8

Intravenous immunoglobulin: pharmacological properties and use in polyneuropathies.

Dézsi L, Horváth Z, Vécsei L. Dézsi L, et al. Expert Opin Drug Metab Toxicol. 2016 Nov;12(11):1343-1358. doi: 10.1080/17425255.2016.1214715. Epub 2016 Aug 22. Expert Opin Drug Metab Toxicol. 2016. PMID: 27428464

9

Alzheimer's disease, astrocytes and kynurenines.

Dezsi L, Tuka B, Martos D, Vecsei L. Dezsi L, et al. Curr Alzheimer Res. 2015;12(5):462-80. doi: 10.2174/156720501205150526114000. Curr Alzheimer Res. 2015. PMID: 26017558 Review.

10

Left ventricular deformation abnormalities in a patient with calpainopathy-a case from the three-dimensional speckle-tracking echocardiographic MAGYAR-Path Study.

Nemes A, Dézsi L, Domsik P, Kalapos A, Forster T, Vécsei L. Nemes A, et al. Among authors: dezsi l. Quant Imaging Med Surg. 2017 Dec;7(6):685-690. doi: 10.21037/qims.2017.10.09. Quant Imaging Med Surg. 2017. PMID: 29312873 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

84 results

Search Page